Charlestown, MA, United States of America

Y Esther Tak

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: The General Hospital Corporation. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Y Esther Tak. Retrieved from https://idiyas.com/inventor/y-esther-tak

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Y Esther Tak: Innovator in Gene Regulation

Introduction

Y Esther Tak is a prominent inventor based in Charlestown, MA (US). She has made significant contributions to the field of gene regulation, particularly through her work with CRISPR technology. With a total of 2 patents to her name, her innovations are paving the way for advancements in genetic research and therapy.

Latest Patents

Y Esther Tak's latest patents include "Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf1." This patent focuses on drug-inducible, tunable, and multiplexable Clustered Regularly Interspaced Short Palindromic Repeats (Cpf1)-based activators, along with methods of use thereof. Her work in this area is crucial for developing more precise and effective gene regulation techniques.

Career Highlights

Y Esther Tak is affiliated with The General Hospital Corporation, where she continues to push the boundaries of genetic research. Her innovative approaches have garnered attention in the scientific community, contributing to the advancement of gene editing technologies.

Collaborations

Some of her notable coworkers include Benjamin Kleinstiver and J Keith Joung. Their collaborative efforts enhance the research environment and foster innovation in gene regulation.

Conclusion

Y Esther Tak is a trailblazer in the field of gene regulation, with her patents and collaborations significantly impacting genetic research. Her work exemplifies the potential of CRISPR technology in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…